WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Sep 28, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-09-26

Reporting Person: MONTECALVO DAVID A (SVP, Glob Ops and Supply Chain)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-26	Common Stock	A	1393.0000	$0.0000	Acquired	1393.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-26	Stock Option (Right to Buy)	$71.7900	A	10792.0000	Acquired	2026-09-26	Common Stock (10792.0000)	Direct

Footnotes

F1: This award vests on 9/26/2021.

F2: This award vests in 4 equal installments beginning on 2/23/2017.